Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Correlates and Control of Blood Pressure Variability
NCT06012487Phase 1Not yet recruiting
- Sponsor
- Cedars-Sinai Medical Center
- Start
- May 2026
- Primary completion
- Dec 2026
- Modality
- Small Molecules
01
Overview
Phase 1, open-label, single-arm trial of amlodipine and indapamide in blood pressure variability (BPV), sponsored by Cedars-Sinai Medical Center. Primary endpoint: Change in Blood Pressure Variability. Planned start May 2026; status: not yet recruiting.
02
Drugs
amlodipineindapamide
03
Conditions
blood pressure variability (BPV)
Beyond the preview
Go deeper on NCT06012487.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06012487.